Protein Crystallization & Crystallography Market Worth $1,253 Million by 2018 - New Report by MarketsandMarkets

The protein crystallography market is segmented on the basis of technologies, applications, products (instruments and reagents), and end users.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend


Leading Players - Rigaku Corporation (Japan), Hampton Research (U.S.), Jena Bioscience GmbH (Germany), Molecular Dimensions Ltd. (U.K.), Formulatrix, Inc. (U.S.), Bruker Corporation (U.S.), and MiTeGen LLC (U.S.)

(PRWEB) April 06, 2014

The “Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market, estimates and forecasts of revenue, and share analysis.

Browse more than 71 market data tables with 20 figures spread through 251 pages and in-depth TOC on "Protein Crystallization & Crystallography Market"

Early buyers will receive 10% customization on this report.

The future growth prospects for the protein crystallization market are optimistic which is estimated to grow at a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018.

Download Free PDF Brochure at

The protein crystallization market is estimated to witness tremendous growth in the next five years as it comprises automated systems that offer very high sensitivity. In addition, protein purification, reagents/consumables, X-ray, and the crystallography segments of the crystallization of protein market are projected to see high growth rates on account of a large number of ongoing research projects in the domain. Thus, the emerging markets of Asia as well as the electrophoresis technology for protein purification are the new revenue sources for the protein crystallization market.

Inquiry Before Buying at

The Americas and Europe are the established markets for protein crystallization & crystallography. The developing regions, including BRIC (Brazil, Russia, India, and China) countries, are expected to form the new revenue pockets for this market. A rise in the spending power of these countries is the major driver for the growth of crystallization of protein. With the advent of new technologies like cryo-crystallization, improved radiation sources, and more sensitive detectors, the protein crystallization and crystallography market will see a robust growth in the near future. The increasing and immediate need for high-resolution information on protein structures, increasing government funding, and increasing R&D in the pharmaceutical and biotechnological arenas are also factors driving the growth of the protein crystallization market. However, lack of qualified and experienced researchers and the highly time-consuming and expensive protein crystallization & crystallography process restricts the growth of the market to some extent.

To take advantage of the favorable conditions in developing economies and to stay ahead of the competition in the global market, a number of Tier-I companies are investing in these countries. For instance, in October 2011, MiTeGen entered into a mutual distribution agreement with Beijing-based XTalQuest, Inc. The agreement helped MiTeGen to expand its product portfolio and increase its distribution chain in China, Taiwan, and Singapore. Similarly, in November 2013, Jena Bioscience entered into a distribution agreement with M. Ayub Brothers (Pakistan), a trading company that deals in consumables. The agreement will help Jena Bioscience to expand its geographic presence.

Among the Asia-Pacific countries, China and India are expected to grow at high CAGRs during the forecast period. This forecasted growth is attributed to increasing prosperity, growing research, and urbanization.

Browse Related Reports:

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018

Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog:
Connect with us on LinkedIn:


Follow us on: Contact's Google Plus